Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
- Authors: Maev I.V.1, Kuznetsova E.I.1, Andreev D.N.1, Dicheva D.T.1
-
Affiliations:
- Yevdokimov Moscow State University of Medicine and Dentistry
- Issue: Vol 92, No 2 (2020)
- Pages: 24-28
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33894
- DOI: https://doi.org/10.26442/00403660.2020.02.000261
- ID: 33894
Cite item
Full Text
Abstract
Aim. Assessment of the diagnostic accuracy of predictive indexes of liver fibrosis for the identification of severe fibrosis and cirrhosis (F3–F4) in patients with chronic hepatitis C (CHC).
Materials and methods. The retrospective design study included 127 patients with chronic hepatitis C (mean age 44.5±11.1 years). To assess the degree of liver fibrosis, all patients underwent transient elastography using a Fibroscan (EchoSens, France) and predictive indexes of liver fibrosis were calculated (APRI, FIB-4, discriminant Bonacini score). Transient elastography was considered as a reference method for assessing the degree of liver fibrosis for subsequent comparison of results with predictive fibrosis indixes.
Results. The sensitivity of the APRI index for the identification of severe fibrosis and cirrhosis of the liver (F3–F4) was 79%, and specificity was 69%. The FIB-4 index showed greater specificity (86%), but less sensitivity (68%). The sensitivity of the discriminant Bonacini scale was 81%, and the specificity was 77%. The positive predictive value of the APRI index, FIB-4 and the Bonacini scale for the identification of severe fibrosis and cirrhosis of the liver (F3–F4) in patients with chronic hepatitis C was 66; 78 and 72% respectively, and negative predictive value – 82; 78 and 84% respectively.
Conclusion. The results of this study indicate the relatively high diagnostic accuracy of a number of predictive indexes for evaluating liver fibrosis (APRI, FIB-4, discriminant Bonachini scale) in identifying severe fibrosis and cirrhosis of the liver (F3–F4) in patients with chronic hepatitis C.
Full Text
##article.viewOnOriginalSite##About the authors
I. V. Maev
Yevdokimov Moscow State University of Medicine and Dentistry
Email: dna-mit8@mail.ru
д.м.н., проф., академик РАН, зав. каф. пропедевтики внутренних болезней и гастроэнтерологии
Russian Federation, MoscowE. I. Kuznetsova
Yevdokimov Moscow State University of Medicine and Dentistry
Email: dna-mit8@mail.ru
клинический ординатор каф. пропедевтики внутренних болезней и гастроэнтерологии
Russian Federation, MoscowD. N. Andreev
Yevdokimov Moscow State University of Medicine and Dentistry
Author for correspondence.
Email: dna-mit8@mail.ru
к.м.н., ассистент каф. пропедевтики внутренних болезней и гастроэнтерологии, н.с. лаб. функциональных методов исследования в гастроэнтерологии
Russian Federation, MoscowD. T. Dicheva
Yevdokimov Moscow State University of Medicine and Dentistry
Email: dna-mit8@mail.ru
к.м.н., доц. каф. пропедевтики внутренних болезней и гастроэнтерологии
Russian Federation, MoscowReferences
- Ющук Н.Д., Климова Е.А., Знойко О.О., Кареткина Г.Н., Максимов С.Л., Маев И.В. и др. Вирусные гепатиты: клиника, диагностика, лечение. 3-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2018 [Yushchuk ND, Klimova EA, Znoiko OO, Karetkina GN, Maksimov SL, Maev IV, et al. Viral hepatitis: a clinic, diagnosis, treatment. 3rd ed. Moscow: GEOTAR-Media, 2018 (In Russ.)].
- Wedemeyer H. Hepatitis C. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Elsevier, 2015.
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. doi: 10.1016/S0140-6736(17)32154-2
- Dore GJ, Hatzakis A, Negro F, Waked I. Estimating HCV disease burden-volume 4 (editorial). J Viral Hepat. 2017;24 Suppl 2:4-7. doi: 10.1111/jvh.12763
- Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S158-64. doi: 10.1016/j.dld.2014.09.023
- Poterucha JJ. Viral hepatitis. In.: Mayo Clinic Gastroenterology and Hepatology Board Review. New York, 2015.
- Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol. 1999;31 Suppl 1:17-24.
- Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48(2):418-31. doi: 10.1002/hep.22375
- Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol. 1998;28(6):930-8.
- Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20(32):11033-53. doi: 10.3748/wjg.v20.i32.11033
- Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-18.
- Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206. doi: 10.1016/j.bpg.2011.02.005
- Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology. 2004;126(2):529-40.
- European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017;66(1):153-94. doi: 10.1016/j.jhep.2016.09.001
- European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006
- Kamath PS, Shah VH. Overview of Cirrhosis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Elsevier, 2015.
- Carey E, Carey WD. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleve Clin J Med. 2010;77(8):519-27. doi: 10.3949/ccjm.77a.09138
- Crespo G, Fernández-Varo G, Mariño Z, Casals G, Miquel R, Martínez SM, et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol. 2012;57(2):281-7. doi: 10.1016/j.jhep.2012.03.016
- Маев И.В., Кузнецова Е.И., Андреев Д.Н., Дичева Д.Т. Современные и перспективные подходы к диагностике неалкогольной жировой болезни печени. Consilium Medicum. 2015;17(8):20-7 [Maev IV, Kuznetsova EI, Andreev DN, Dicheva DT. Current and future approaches to the diagnosis of non-alcoholic fatty liver disease. Consilium Medicum. 2015;17(8):20-7 (In Russ.)].
- Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-26. doi: 10.1053/jhep.2003.50346
- Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, et al. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics (Sao Paulo). 2017 Oct;72(9):516-25. doi: 10.6061/clinics/2017(09)01
- Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32-6. doi: 10.1002/hep.21669
- Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92(8):1302-4.
- Advances in Clinical Chemistry. Vol. 70. 1st ed. Academic Press, 2015.
- Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013;158(11):807-20. doi: 10.7326/0003-4819-158-11-201306040-00005
- Морозов С.В., Кучерявый Ю.А., Стукова Н.Ю., Краснякова Е.А. Непрямая ультразвуковая эластография печени: от диагностики фиброза печени – к контролю над лечением. Доказательная гастроэнтерология. 2013;(2):31-7 [Morozov SV, Kucheriavyi IuA, Stukova NIu, Krasniakova EA. Indirect ultrasound elastography of the liver: from diagnostics of liver fibrosis to control over its treatment. Dokazatelnaya Gastroenterologiya. 2013;(2):31-7 (In Russ.)].
- Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960-74. doi: 10.1053/j.gastro.2008.01.034
- Schmid P, Bregenzer A, Huber M, Rauch A, Jochum W, Müllhaupt B, et al. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PLoS One. 2015;10(9):e0138838. doi: 10.1371/journal.pone.0138838. eCollection 2015.
- Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, et al. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis. 2015;60(6):950-8. doi: 10.1093/cid/ciu939
- Dolmazashvili E, Karchava M, Abutidze A, Sharvadze L, Tsertsvadze T. Comparative study of FIB-4 index and transient elastography among patients with chronic hepatitis C virus infection in Georgia. Georgian Med News. 2017;(264):81-6.
- Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, et al. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat. 2015;22(3):245-53. doi: 10.1111/jvh.12285
- Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver Fibrosis by Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2016;6(4):282-90. doi: 10.1016/j.jceh.2016.08.001